Navigation Links
Millennium HealthCare Appoints Ed Joyce to Company Advisory Board
Date:3/7/2012

SYOSSET, N.Y., March 7, 2012 /PRNewswire/ -- Millennium HealthCare Inc. (OTC Pink: MHCC) announced the appointment of Ed Joyce to the Company Advisory Board.

Millennium President Chris Amandola commented, "Ed brings deep experience from multiple healthcare disciplines and we are honored to have him join our advisory board.  Our Company's advantage is to have a group of highly trained, successful and resourceful individuals and he will be a tremendous addition to our team."

"Edward Joyce has over 17 years experience in medical sales and medical sales management and has a long history of success with leading medical device manufacturers such as C.R. Bard Inc., Edwards Life Sciences and St. Jude Medical.  His expertise includes, but is not limited to, managing as well as building professional sales organizations.  Throughout Edward's career he has called on numerous areas of hospitals including Infection Control, Housekeeping, Cardiology, Radiology, ICU's as well as the Operating Room.   In each of these departments Edward has built tremendous relationships across the United States and brings with him a large network of KOL's in each of these areas.  Edward has also successfully managed to launch a variety of new technology in which he had a key role in both sales related and marketing related strategies and we look forward to working together. "

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995   

Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

 


'/>"/>
SOURCE Millennium HealthCare Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting
2. Millennium Research Institute Announces 2012 Educational Initiatives
3. Millennium Surgical Corp. Provides Instruments to Latter Day Saints Charities for Humanitarian Projects
4. Millennium HealthCare Developing and Managing First Vascular Ambulatory Surgical Center
5. Millennium HealthCare Inc. Engages KBL, LLP
6. Millennium Surgical Provides Services and Support to CURE Internationals Zambian Surgical Program
7. Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx®
8. Zen Holding Corp. Changes Name to Millennium HealthCare Inc.
9. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
10. Millennium Surgicals Smart Instrument Purchasing Saves OR Personnel Time, Money
11. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):